Fabre-Kramer Pharmaceuticals, Inc., Houston, TX and Mission Pharmacal Company, San Antonio, TX have signed agreements providing for Mission to complete the technology transfer to develop and manufacture the registration batches of Fabre-Kramer’s novel antidepressant, Travivo (gepirone HCl) Extended Release Tablets. Data from these batches will be used to support the submission of the NDA Amendment for Travivo to the…